Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
07/2008
07/30/2008CN101229371A Use of anti-TNFalpha antibodies and another drug
07/30/2008CN101229370A Autologous T-cell vaccines against multiple sclerosis
07/30/2008CN101229364A Scorpion toxin spray and preparing method thereof
07/30/2008CN101229355A Rheumatism soup
07/30/2008CN101229353A Medicine compounds for treating rheumatoid and atrophic arthritis
07/30/2008CN101229352A Total nutrition wine for treating rheumatic disease and preparing method thereof
07/30/2008CN101229344A Chinese traditional medicine composite for treating heart disease and preparing method thereof
07/30/2008CN101229334A Medicine for treating rheumatoid and atrophic arthritis
07/30/2008CN101229328A Method of extracting eucalyptus and bamboo wood flavonoid
07/30/2008CN101229313A Hotspring powder medicine compounds
07/30/2008CN101229298A Externally used paste for treating wound, osteomyelitis and preparing method thereof
07/30/2008CN101229295A Bone regeneration pain-relieving plaster
07/30/2008CN101229294A Medicated wine capable of promoting blood circulation by removing blood stasis, detumescence and relieving pain
07/30/2008CN101229283A Zhongganling capsule and preparing method thereof
07/30/2008CN101229281A Medicine for treating rheumatoid arthritis
07/30/2008CN101229271A Rheumatism ostealgia medicated wine and preparing method thereof
07/30/2008CN101229268A Retinervus-smoothing regeneration ointment
07/30/2008CN101229264A Chinese traditional medicine prescription and preparation of active ingredient thereof
07/30/2008CN101229255A Chinese traditional medicine formulation for treating acute waist injury
07/30/2008CN101229245A Chinese traditional medicine for treating arthralgia, myalgia and numbness of extremities
07/30/2008CN101229244A Adjuvant therapy rheumatoid arthritis external medicine and preparing method thereof
07/30/2008CN101229240A Nasil powdered medicine for ache
07/30/2008CN101229228A Medicine compounds for treating angiitis, phlebitis, osteomyelitis and preparing method thereof
07/30/2008CN101229216A External mixture of Chinese traditional medicine for treating ache
07/30/2008CN101229204A Process for preparing bupleurum total saponin
07/30/2008CN101229203A Valid target of common peganum seed, preparing method and uses of dehydrogenization telepathine monomer
07/30/2008CN101229141A Aspirin sustained release tablet and preparing method thereof
07/30/2008CN100406891C 利用EPF受体鉴定结合或调节hDRR活性的化合物以及hDRR的分离 Identification of isolated compounds utilizing EPF receptor binding or regulate the activity and hDRR of hDRR
07/30/2008CN100406562C Humanized immunoglobulin reactive with alpha 4 beta 7 integrin
07/30/2008CN100406459C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
07/30/2008CN100406454C Pyrazole compounds useful as protein kinase inhibitors.
07/30/2008CN100406441C Cyclic amine compounds
07/30/2008CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these
07/30/2008CN100406047C Chinese medicine for treating rheumatosis and rheumatoid disease
07/30/2008CN100406044C Medicine for treating fracture and injury
07/30/2008CN100406012C Hydrobromic acid high tortoiseshell component drip pill and its preparation method
07/30/2008CN100406008C Pharmaceutical composition comprising lumiracoxib
07/29/2008US7405306 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease
07/29/2008US7405225 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
07/29/2008US7405223 Treating allergic and inflammatory conditions
07/29/2008US7405212 Helix mimetics and composition and methods related thereto
07/29/2008US7405211 Therapeutic morpholino-substituted compounds
07/29/2008US7405206 Administering by inhalation; antiinflammatory agents, antiallergens; skin disorders; reacting androstane compound with 2-oxofuran compound
07/29/2008US7405200 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis
07/29/2008US7405049 Elevated concentration of given protein is indicative of sepsis or Alzheimer's disease; procalcitonin biomarker; immunoassay
07/29/2008US7404953 anti-human interleukin-5 receptor alpha -chain monoclonal antibody; asthma; atopic dermatitis
07/29/2008CA2460939C Substituted pyrazolyl compounds for the treatment of inflammation
07/29/2008CA2438813C Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists
07/29/2008CA2432222C Pyrazole compounds useful as protein kinase inhibitors
07/29/2008CA2432132C Pyrazole compounds useful as protein kinase inhibitors
07/29/2008CA2409842C 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
07/29/2008CA2382322C Aminocarbonyl-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions
07/29/2008CA2348742C Carbocyclic potassium channel inhibitors
07/29/2008CA2337755C Inhibitors of p38
07/29/2008CA2333656C A novel vla-4 inhibitor: omepupa-v
07/29/2008CA2333008C New heterocyclically substituted amides, their production and their use
07/29/2008CA2261835C Long-acting drugs and pharmaceutical compositions comprising them
07/29/2008CA2218702C Fatty acid esters as bioactive compounds
07/29/2008CA2218096C New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds
07/29/2008CA2175767C Adhesion receptor antagonists
07/29/2008CA2141842C Novel glycoforms of soluble complement receptor 1
07/24/2008WO2008089478A2 Thermotherapy susceptors and methods of using same
07/24/2008WO2008088047A1 Method for glycosylation of flavonoid
07/24/2008WO2008087933A1 NOVEL INDOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON IϰB KINASE β
07/24/2008WO2008087512A1 Morpholine dopamine agonists for the treatment of pain
07/24/2008WO2008087371A1 New combination for use in the treatment of inflammatory disorders
07/24/2008WO2008086750A1 Mixed fermentation method of callicarpa dichotoma (lour.) k. koch and edible fungus, prepared products via the method and uses thereof
07/24/2008WO2008086698A1 A forsythoside injection and preparation thereof
07/24/2008WO2008070129A3 Compositions and methods for the treatment of inflammatory disease
07/24/2008WO2008060764A3 Topical therapies for oral mucositis and other conditions
07/24/2008WO2008058938A3 Hypericum and derivatives thereof as analgesic potentiating agents
07/24/2008WO2008053352A3 Phenylpropionamide compounds and the use thereof
07/24/2008WO2008011392A8 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation
07/24/2008WO2008005538A3 Methods of using igf1r and abl kinase modulators
07/24/2008WO2007077574A8 SULFOXIMINE DERIVATIVES AS p38 MAP KINASE INHIBITORS
07/24/2008US20080177082 N3 alkylated benzimidazole derivatives as mek inhibitors
07/24/2008US20080177064 Dipeptidyl peptidase inhibitors
07/24/2008US20080177042 Leucine-based motif and clostridial neurotoxins
07/24/2008US20080177041 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders
07/24/2008US20080177037 Leucine-based motif and clostridial neurotoxins
07/24/2008US20080176961 Phosphodiesterase acitvity and regulation of phosphodiesterase 1-B-mediated signaling in brain
07/24/2008US20080176944 Elongase Genes and Uses Thereof
07/24/2008US20080176903 Novel Compounds with Analgesic Effect
07/24/2008US20080176897 Substituted Quinolone Carboxylic Acids, Their Derivatives, Site of Action, And Uses Thereof
07/24/2008US20080176891 N-(2-Aminoethyl)-4-(2-ethyl-1H-pyrrolo[2,3-b]pyridin-4-yl)benzene-sulfonamide; respiratory disorders; rheumatoid arthritis
07/24/2008US20080176870 Heterobicyclic metalloprotease inhibitors
07/24/2008US20080176846 e.g. 3-(5-amino-2-methylphenyl)-7-chloro-1-methyl-1,6-naphthyridin-2(1H)-one; protein kinase inhibitor; antiinflammatory, anticarcinogenic, antiallergen, antidiabetic, antiischemic, hypotensive agent
07/24/2008US20080176841 (amidomethyl-amido)-(carboxy/amido)epoxide derivatives; cathepsin inhibitor; antiinflammatory, anticarcinogenic, antidiabeticagent, antiallergen, autoimmune and neurodegenerative disorders
07/24/2008US20080176840 e.g. 4-(4-(6-(N-(2-methoxyethyl)-N-methylamino)pyridin-3-yl)-5-hydroxy-4H-1,2,4-triazol-3-yl)-6-isopropylbenzene-1,3-diol; Heat Shock Protein 90 (HSP90) modulator; antiproliferative, anticarcinogenic, antiinflammatory agent; angiogenesis inhibition, infections
07/24/2008US20080176830 Compounds, Compositions, and Methods
07/24/2008US20080176820 Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro
07/24/2008US20080176815 Compounds that interact with kinases
07/24/2008US20080176814 nonpeptidic inhibitors of cathepsin G; genetic diseases, degenerative diseases, DNA damages, neoplasia and/or skin diseases; DNA or polynucleotide sequences having a chain length of at least 60 nucleotides and being substantially not subjected to undergo efficient base pairing
07/24/2008US20080176795 administering human H3 relaxin, carriers, diluents and/or excipients; anxiolytic agents; hormones
07/24/2008US20080176323 Expression vector comprising nucleotide sequences coding cytokine polypeptide for use in treatment and prevention of lung, viral, cell proliferative and inflammatory diseases
07/24/2008US20080175914 Inflammatory and/or allergic diseases; cognitive impairment
07/24/2008US20080175853 Virus-like particles for the induction of autoantibodies
07/24/2008US20080175841 Antagonistic Anti-hTNFSF13b Human Antibodies
07/24/2008US20080175840 Methods for treating angiogenesis related disorders
07/24/2008US20080175828 Proliferated cell lines and uses thereof